Education
About Us
Working with TipRanks
Follow Us
Sagimet Biosciences, Inc. Class A (SGMT)
NASDAQ:SGMT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 2.00M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 2.00M | $ -130.00K | $ -134.00K | $ -124.00K |
| Operating Income | $ -54.45M | $ -30.74M | $ -31.05M | $ -23.72M | $ -11.40M |
| EBITDA | $ -54.45M | $ -30.74M | $ -30.37M | $ -24.31M | $ -11.25M |
| Net Income | $ -45.57M | $ -27.88M | $ -30.50M | $ -24.44M | $ -11.37M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 151.25M | $ 94.90M | $ 32.34M | $ 56.73M | $ 68.70M |
| Total Assets | $ 160.26M | $ 96.72M | $ 33.03M | $ 59.03M | $ 68.96M |
| Total Debt | $ 78.00K | $ 65.00K | $ 211.00K | $ 348.00K | $ 210.00K |
| Net Debt | $ -75.76M | $ -75.07M | $ 53.00K | $ -56.38M | $ -68.49M |
| Total Liabilities | $ 4.45M | $ 5.65M | $ 219.98M | $ 217.29M | $ 204.87M |
| Stockholders' Equity | $ 155.81M | $ 91.06M | $ -186.95M | $ -158.26M | $ -135.91M |
| Cash Flow | |||||
| Free Cash Flow | $ -42.44M | $ -23.77M | $ -24.49M | $ -21.71M | $ -10.42M |
| Operating Cash Flow | $ -42.44M | $ -23.77M | $ -24.49M | $ -21.71M | $ -10.42M |
| Investing Cash Flow | $ -61.68M | $ 12.58M | $ -32.01M | $ 0.00 | $ 20.00K |
| Financing Cash Flow | $ 104.82M | $ 86.17M | $ -73.00K | $ 9.74M | $ 68.89M |